Carvedilol
Product Images NDC 53002-1573

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 53002-1573). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

A survival analysis plot titled 'Survival Analysis for COPERNICUS (Intent-to-Treat)' comparing mortality percentages over 21 months between Carvedilol and Placebo groups. The graph shows % mortality on the y-axis and months on the x-axis, with the Carvedilol group having lower mortality than the Placebo group.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

A horizontal forest plot illustrating the effects on mortality for various subgroups in the COPERNICUS study. The chart shows hazard ratios for groups including men, women, age categories, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, with a vertical reference line at hazard ratio 1.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

A survival analysis line graph titled 'Survival Analysis for CAPRICORN (Intent-to-Treat)' comparing mortality percentages over 24 months between Carvedilol and placebo groups. The x-axis represents months and the y-axis shows percentage mortality, with Carvedilol showing lower mortality than placebo throughout the period.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

A forest plot figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratios with confidence intervals for various patient subgroups, including age, gender, timing post-MI, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA usage, CHF status, diuretic use, angina, hypertension, diabetes, heart rate, systolic blood pressure, and overall patient population.*

FDA Label Image

Chemical Structure (Carvedilol Str)

Chemical structure of Carvedilol as presented in the image. The structure includes an indole moiety, an ether linkage, and a methoxyphenyl group with an attached hydroxy and amine side chain.*

FDA Label Image

Label Image (Lbl530021556)

Label for Carvedilol 6.25 mg tablets by RPK Pharmaceuticals, Inc. The package contains 30 tablets with directions to take one tablet twice a day or as directed by a doctor. The label includes patient information, lot number, expiration date, billing NDC codes, and pharmacy contact details. The dosage form is oral tablets.*

FDA Label Image

Label Image (Lbl530021572)

Carvedilol 3.125 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets with instructions to take one tablet twice a day or as directed by a healthcare provider. It includes patient name, lot number, expiration date, and spaces for clinic and pharmacist information.*

FDA Label Image

Label Image (Lbl530021573)

Carvedilol 12.5mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets with directions to take 1 tablet twice a day or as prescribed. The label includes patient name, prescribing instructions, manufacturing and distributor information, billing NDC numbers, lot number, and discard date.*

FDA Label Image

Label Image (Lbl530021574)

Carvedilol 25mg tablets packaging label, containing 30 tablets. The label includes directions to take one tablet twice a day or as directed by a healthcare provider. It is manufactured by RPK Pharmaceuticals, Inc. The label also shows lot and expiration dates, billing information, and space for patient and clinic details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.